UTHR

United Therapeutics CORP

+$5.5B

Net Activity

Institutions Holding

846

Popularity Rank

#562

Avg Weight

0.29%

Total Value

$26.4B

Ownership Trend

846 institutions currently hold UTHR, with 398 net buyers and 403 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

403

Net Buying Institutions

398

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$3.2B
AC
Avoro Capital Advisors LLC
$1.6B
WM
Wellington Management Group LLP
$1.3B
VP
Vanguard Portfolio Management LLC
$1.2B
VC
Vanguard Capital Management LLC
$1.2B

Top 5 by Conviction

AC
Avoro Capital Advisors LLC
15.44%
EP
Eversept Partners, LP
8.26%
SI
Sofinnova Investments, Inc.
5.42%
SC
Soleus Capital Management, L.P.
4.50%
CM
Caption Management, LLC
3.99%
View all 846 holding institutions

Quarterly Activity

Recent Activity

+$16.4B

Total Buy Value

$7.8B

Total Sell Value

New buy96
Trim321
Add302
Sold out82

398

Net Buyers

403

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

5

Filings (90d)

$127.04M

Total Est. Value

234K shares

Planned Shares

Last Filed 2026-07-10
FilerFiling DateEst. Value
JAN MALCOLM2026-07-10$179K
PAUL MAHON2026-07-02$4.59M
MARTINE ROTHBLATT2026-07-01$113.24M
MAHON PAUL A2026-06-18$4.49M
MAHON PAUL A2026-06-04$4.54M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding UNITED THERAPEUTICS CORP (UTHR)?
Major stakeholders currently include BlackRock, Inc. ($3.2B), Avoro Capital Advisors LLC ($1.6B), Wellington Management Group LLP ($1.3B). Based on the latest 13F filings, there are a total of 846 tracked investment funds and institutions maintaining positions in UTHR.
What is the overall institutional sentiment toward UTHR recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $5.5B, driven by 398 managers accumulating shares while 403 reduced their exposure.
Which institutions have been selling or reducing their UTHR positions?
In the latest period, 321 funds trimmed their holdings, and 82 managers completely exited their positions. The aggregate reported sell value was $7.8B.
Are there any notable investors adding UTHR to their portfolios?
Yes, buying activity remains notable. 96 institutions opened new positions in {ticker}, and 302 existing holders added to their shares. The total reported buy value for the quarter amounted to $16.4B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

750 institutions currently hold both UTHR and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

763 institutions currently hold both UTHR and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

728 institutions currently hold both UTHR and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail